The E545K and E545A mutations in PIK3CA have not only been detected upon progression in advanced ALK‐positive NSCLC patients, but also in EGFR‐positive NSCLC patients [28, 29]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.